标题
How does TCR-T cell therapy exhibit a superior anti-tumor efficacy
作者
关键词
-
出版物
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume -, Issue -, Pages 149209
出版商
Elsevier BV
发表日期
2023-11-03
DOI
10.1016/j.bbrc.2023.149209
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds
- (2023) Yeqin Yuan et al. Biomolecules
- Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors
- (2023) Lena Immisch et al. Frontiers in Immunology
- One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation
- (2023) Donovan Flumens et al. STAR Protocols
- Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy
- (2023) Garry Dolton et al. CELL
- Challenges and new technologies in adoptive cell therapy
- (2023) Pengchao Zhang et al. Journal of Hematology & Oncology
- Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity
- (2023) Peter M. K. Westcott et al. NATURE GENETICS
- Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
- (2022) Jingjing He et al. CELL RESEARCH
- T cell receptors (TCRs) employ diverse strategies to target a p53 cancer neoantigen
- (2022) Daichao Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function
- (2022) Eliana Ruggiero et al. Science Translational Medicine
- Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure
- (2022) Tassilo L. A. Wachsmann et al. OncoImmunology
- Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer
- (2022) George R Blumenschein et al. Journal for ImmunoTherapy of Cancer
- It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
- (2022) Che-Pei Kung et al. Frontiers in Cell and Developmental Biology
- A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity
- (2022) Yuki Yajima et al. CANCER SCIENCE
- Type I interferon-mediated tumor immunity and its role in immunotherapy
- (2022) Renren Yu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tumor cell-based vaccine: an effective strategy for eradication of cancer cells
- (2022) Seyed Amir Sadeghi Najafabadi et al. Immunotherapy
- Therapeutics Targeting p53-MDM2 Interaction to Induce Cancer Cell Death
- (2022) Nayeong Koo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Engineered cellular immunotherapies in cancer and beyond
- (2022) Amanda V. Finck et al. NATURE MEDICINE
- Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
- (2022) Smita S. Chandran et al. NATURE MEDICINE
- MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression
- (2022) Celeste Giansanti et al. Cell Reports
- Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
- (2022) Paul Shafer et al. Frontiers in Immunology
- CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy
- (2022) Rosanna Mezzapelle et al. Cancers
- Rapid generation of genetically engineered T cells for the treatment of virus‐related cancers
- (2022) Jinxing Jiang et al. CANCER SCIENCE
- Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK ‐rearranged non‐small cell lung cancer
- (2022) Takuya Sakashita et al. CANCER SCIENCE
- NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome
- (2022) Mikiya Ishihara et al. Journal for ImmunoTherapy of Cancer
- Efficacy of pp65‐specific TCR‐T cell therapy in treating cytomegalovirus infection after hematopoietic stem cell transplantation
- (2022) Guangna Liu et al. AMERICAN JOURNAL OF HEMATOLOGY
- CRISPR/Cas9-medaited knockout of endogenous T-cell receptor in Jurkat cells and generation of NY-ESO-1-specific T cells: An in vitro study
- (2022) Pouya Safarzadeh Kozani et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype
- (2022) Synat Kang et al. ONCOGENE
- Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen
- (2022) Andrew Poole et al. Nature Communications
- Challenges in neoantigen-directed therapeutics
- (2022) Lien Lybaert et al. CANCER CELL
- Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cells
- (2022) Sizhen Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Time required for commitment to T cell proliferation depends on TCR affinity and cytokine response
- (2022) Liang‐zhe Wu et al. EMBO REPORTS
- p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies
- (2022) Chahat et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
- (2022) Valeria Lucarini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Acetyl-CoA, protein acetylation, and liver cancer
- (2022) Zhengming Wu et al. MOLECULAR CELL
- Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
- (2022) Rona Yaeger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid identification of CMV-specific TCRs via reverse TCR cloning system based on bulk TCR repertoire data
- (2022) Cheol-Hwa Hong et al. Frontiers in Immunology
- Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2Prame complex
- (2021) Wenjuan Zhang et al. CELL DEATH AND DIFFERENTIATION
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
- (2021) Nisha B. Nagarsheth et al. NATURE MEDICINE
- Targeting a neoantigen derived from a common TP53 mutation
- (2021) Emily Han-Chung Hsiue et al. SCIENCE
- Avidity optimization of a MAGE‐A1‐specific TCR with somatic hypermutation
- (2021) David Bassan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Role of Virus-Induced Host Cell Epigenetic Changes in Cancer
- (2021) Valeria Pietropaolo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Histone citrullination: a new target for tumors
- (2021) Dongwei Zhu et al. Molecular Cancer
- Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy
- (2021) Yi Sun et al. Science Translational Medicine
- Targeting cancer testis antigens in synovial sarcoma
- (2021) Geoffrey Mitchell et al. Journal for ImmunoTherapy of Cancer
- NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness
- (2021) Mireia Bachiller et al. Journal for ImmunoTherapy of Cancer
- Virus-Driven Carcinogenesis
- (2021) Yuichiro Hatano et al. Cancers
- Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer
- (2021) Yimo Sun et al. Cells
- Protein Phosphorylation in Cancer: Role of Nitric Oxide Signaling Pathway
- (2021) Xinran Liu et al. Biomolecules
- Tumor associated antigen specific T cells with nivolumab are safe and persist in vivo in rel/ref Hodgkin Lymphoma
- (2021) Hema Dave et al. Blood Advances
- Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery
- (2021) Jipeng Jiang et al. ADVANCED DRUG DELIVERY REVIEWS
- Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
- (2021) Fanping Meng et al. Hepatology International
- Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy
- (2021) Guy Handley et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Identification of tumor antigens with immunopeptidomics
- (2021) Chloe Chong et al. NATURE BIOTECHNOLOGY
- Pathogenicity of the MAGE family (Review)
- (2021) Sanyan Li et al. Oncology Letters
- Protein modifications throughout the lung cancer proteome unravel the cancer-specific regulation of glycolysis
- (2021) Yangmiao Duan et al. Cell Reports
- Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
- (2021) Christopher Sloas et al. Frontiers in Immunology
- Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
- (2021) Xinle Cui et al. Frontiers in Immunology
- Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors
- (2021) Chia-Ing Jan et al. Journal for ImmunoTherapy of Cancer
- Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer
- (2020) Mizuho Ohara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Microenvironment
- (2020) Borros Arneth Medicina-Lithuania
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells
- (2020) Cyril Corbet et al. Nature Communications
- Computational Prediction and Validation of Tumor-Associated Neoantigens
- (2020) Vladimir Roudko et al. Frontiers in Immunology
- Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection
- (2020) Zhongji Meng et al. Frontiers in Immunology
- A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting
- (2020) Lihua Shu et al. MOLECULAR CANCER THERAPEUTICS
- High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
- (2020) Malcolm J. W. Sim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells
- (2020) Lun Cai et al. Frontiers in Immunology
- Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit
- (2020) Xiaobing Luo et al. Frontiers in Immunology
- Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy
- (2020) Wei Wu et al. CELL
- Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma
- (2020) Yifei Zheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Targeting p53 for the treatment of cancer
- (2020) Michael J. Duffy et al. SEMINARS IN CANCER BIOLOGY
- Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
- (2020) Daichao Wu et al. Nature Communications
- KRAS: From undruggable to a druggable Cancer Target
- (2020) Dipesh Uprety et al. CANCER TREATMENT REVIEWS
- HBV as a target for CAR or TCR-T cell therapy
- (2020) Antonio Bertoletti et al. CURRENT OPINION IN IMMUNOLOGY
- Emerging Roles of the MAGE Protein Family in Stress Response Pathways
- (2020) Rebecca R Florke Gee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of Functional HLA-A*01:01–Restricted Epstein-Barr Latent Membrane Protein 2–Specific T-Cell Receptors
- (2020) Wesley Huisman et al. JOURNAL OF INFECTIOUS DISEASES
- The role of ubiquitination and deubiquitination in cancer metabolism
- (2020) Tianshui Sun et al. Molecular Cancer
- Structural dissimilarity from self drives neoepitope escape from immune tolerance
- (2020) Jason R. Devlin et al. Nature Chemical Biology
- Phosphorylation regulates cullin-based ubiquitination in tumorigenesis
- (2020) Yifan Chen et al. Acta Pharmaceutica Sinica B
- Recent developments in immunotherapy of cancers caused by human papillomaviruses
- (2020) Elham Fakhr et al. IMMUNOLOGY
- Tumor microenvironment as a therapeutic target in cancer
- (2020) Yi Xiao et al. PHARMACOLOGY & THERAPEUTICS
- Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures
- (2019) Dongqiang Zeng et al. Cancer Immunology Research
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
- (2019) Parisa Malekzadeh et al. JOURNAL OF CLINICAL INVESTIGATION
- The function of RAS mutation in cancer and advances in its drug research
- (2019) Shijie Chen et al. CURRENT PHARMACEUTICAL DESIGN
- Optimizing T‐cell receptor avidity with somatic hypermutation
- (2019) David Bassan et al. INTERNATIONAL JOURNAL OF CANCER
- T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
- (2019) Stacey L. Doran et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor neoantigens: from basic research to clinical applications
- (2019) Tao Jiang et al. Journal of Hematology & Oncology
- Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
- (2019) Peter T Harrison et al. SEMINARS IN CANCER BIOLOGY
- Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy
- (2019) Timothy T. Spear et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming
- (2019) Alexandre P. Bénéchet et al. NATURE
- Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
- (2019) Joseph P Sanderson et al. OncoImmunology
- Identification of an HLA‐A*24:02‐restricted α ‐fetoprotein signal peptide‐derived antigen and its specific T‐cell receptor for T‐cell immunotherapy
- (2019) Zhenjuan Li et al. IMMUNOLOGY
- Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy
- (2018) Wei Zhu et al. HEPATOLOGY
- A humanized TCR retaining authentic specificity and affinity conferred potent anti-tumour cytotoxicity
- (2018) Lin Chen et al. IMMUNOLOGY
- More than just oncogenes: mechanisms of tumorigenesis by human viruses
- (2018) Marta M Gaglia et al. Current Opinion in Virology
- Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM
- (2017) Haitao Ge et al. INTERNATIONAL JOURNAL OF CANCER
- A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
- (2017) Aaron Y. Chang et al. JOURNAL OF CLINICAL INVESTIGATION
- Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
- (2017) Ifigeneia Tzannou et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA + Metastatic Colorectal Cancers
- (2017) Chengcheng Zhang et al. MOLECULAR THERAPY
- Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B
- (2017) Paola Fisicaro et al. NATURE MEDICINE
- Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
- (2017) Waseem Qasim et al. Science Translational Medicine
- Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms
- (2017) Danilo Presotto et al. Frontiers in Immunology
- HCV T Cell Receptor Chain Modifications to Enhance Expression, Pairing, and Antigen Recognition in T Cells for Adoptive Transfer
- (2017) Kendra C. Foley et al. Molecular Therapy-Oncolytics
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection
- (2016) Souheil-Antoine Younes et al. JOURNAL OF CLINICAL INVESTIGATION
- Adaptive immunity in HBV infection
- (2016) Antonio Bertoletti et al. JOURNAL OF HEPATOLOGY
- The MAGE protein family and cancer
- (2015) Jenny L Weon et al. CURRENT OPINION IN CELL BIOLOGY
- Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice
- (2015) Matthias Obenaus et al. NATURE BIOTECHNOLOGY
- Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma
- (2015) Longhao Sun et al. TUMOR BIOLOGY
- Signaling in Lymphocyte Activation
- (2015) Doreen Cantrell Cold Spring Harbor Perspectives in Biology
- Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors
- (2015) Q. J. Wang et al. Cancer Immunology Research
- TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer
- (2014) B Berdien et al. GENE THERAPY
- Functional Comparison of Engineered T Cells Carrying a Native TCR versus TCR-like Antibody–Based Chimeric Antigen Receptors Indicates Affinity/Avidity Thresholds
- (2014) Ravit Oren et al. JOURNAL OF IMMUNOLOGY
- RNAi-mediated TCR Knockdown Prevents Autoimmunity in Mice Caused by Mixed TCR Dimers Following TCR Gene Transfer
- (2014) Mario Bunse et al. MOLECULAR THERAPY
- Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
- (2012) Elena Provasi et al. NATURE MEDICINE
- Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety
- (2011) T. Ochi et al. BLOOD
- The molecular basis of the failed immune response in chronic HBV: Therapeutic implications
- (2010) Mala K. Maini et al. JOURNAL OF HEPATOLOGY
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now